DCI

Cincinnati, Ohio 45206

0 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Disease, Chronic Renal Failure, Chronic Renal Insufficiency, End-Stage Renal Disease, Hyperphosphatemia, Secondary Hyperparathyroidism

Studies at this site

• A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease — Completed
• Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects — Completed